Knowledge of the molecular architecture of CTCs is accessing novel organ specific markers that improve information regarding tumor stage, metastatic capability, progression and response to therapy.

The thesis aims to expand knowledge about various tumor biological markers in papillary thyroid cancer and their significance for disease recurrence, says Lindfors. We have examined various ...

Researchers have developed a personalized blood test that may offer a faster, less invasive way to track high-grade glioma progression.

In the last few years, much attention has been paid to this novel tumor marker that can be determined in EDTA-plasma and in the feces. It has been used in diagnosis and surveillance of a variety ...

Here, we demonstrate the potential of such an approach by conducting one-shot, 3D 15-plex (that is, multiplexing with 15 markers) experiments on mouse tumor tissue (Fig. 1a). The choice of 15 ...